J.L. Bainbridge Exits Most of Biogen Stake as Biotech Stock Eyes Turnaround
Werte in diesem Artikel
Florida-based wealth advisory J. L. Bainbridge & Co. sold 119,376 shares of Biogen (NASDAQ:BIIB) during the third quarter for an estimated $16.1 million.In a quarterly disclosure filed with the Securities and Exchange Commission on Friday, J. L. Bainbridge & Co. Inc. reported selling 119,376 shares of Biogen (NASDAQ:BIIB) during the third quarter. The estimated value of the shares sold was $16.1 million, based on the average closing price for the period. The fund now holds just 2,969 shares of Biogen valued at $415,898 as of September 30.The sale reduced Biogen to 0.03% of reported U.S. equity assets under management as of September 30. Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Ausgewählte Hebelprodukte auf Biogen
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Biogen
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: MotleyFool
Nachrichten zu Biogen Inc Unsponsored Brazilian Depository Receipt Repr 1-6 Shs
Analysen zu Biogen Inc Unsponsored Brazilian Depository Receipt Repr 1-6 Shs
Keine Analysen gefunden.